alexa Serological Assessment of Samples from Patients Complaining of and#8216;Dyspepsiaand#8217; | OMICS International | Abstract
ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Serological Assessment of Samples from Patients Complaining of ‘Dyspepsia’

Stephen Mortlock*

Global Infectious Diseases and Microbiology Liaison, Quest Diagnostics, Cranford Lane, Heston, UK

*Corresponding Author:
Dr. Stephen Mortlock
Department of Molecular Biology, Quest Diagnostics
Cranford Lane, Heston, Middlesex TW5 9QA, UK
E-mail: [email protected]

Received date: June 18, 2013; Accepted date: October 21, 2013; Published date: October 30, 2013

Citation: Mortlock S (2013) Serological Assessment of Samples from Patients Complaining of ‘Dyspepsia’. J Gastroint Dig Syst 3:145. doi: 10.4172/2161-069X.1000145

Copyright: © 2013 Mortlock S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Background: Many people consult their GP for upper gastrointestinal (GI) symptoms, which are often associated with pain or burning and discomfort in the abdomen and range from heartburn and acid regurgitation to nausea and vomiting. Historically, all of these symptoms have been grouped together under the single term ‘dyspepsia’, defined as having one or more symptoms of epigastric pain, burning, postprandial fullness, or early satiation. While gastric or oesophageal cancer is an unusual finding in patients with dyspepsia, excluding malignancy is a common reason for performing endoscopy.

Methods: Quest Diagnostics has been offering the GastroPanel® assays for those patients who have been referred to the walk-in clinic complaining of ‘dyspepsia’. This is a set of three assays (Pepsinogen I, Gastrin 17 and Helicobacter pylori) and the results use an algorithm which can provide information about the stomach health and about the function of the stomach mucosa.

Results: Of all the samples tested 63.5% showed no abnormalities and were reported as ‘normal function of gastric mucosa.’ These patients would be classed as having functional dyspepsia. Thirty-six samples (19.9%) were positive for Helicobacter pylori and the remaining samples had a variety of abnormal results.

Conclusion: Dyspepsia is a common problem seen both by primary care physicians and gastroenterologists. Using the results from the serological analysis of the patients’ serum the clinician can delineate between gastric atrophy and a normal health stomach usually without the need to refer the patient for endoscopy.

Keywords

Recommended Conferences
Share This Page
Top